Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 7,278 shares at $159.28 ($1.2M) on 2025-12-09, disclosed to the SEC on 2025-12-11.
Open-market sale of $1.2M WGS by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.28 | 3,639 | $580K | 50.0% |
| 2 | $159.28 | 3,639 | $580K | 50.0% |
| Total | $159.28 avg | 7,278 | $1.2M | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |